The Health Innovation Network’s National Lipid Optimisation & Familial Hypercholesterolaemia (FH) Programme has delivered huge impact in its goal to reduce the prevalence of cardiovascular disease and its associated health inequalities, according to the programme’s new Impact Report.
The report celebrates the collective achievements of the programme, which has increased the detection of people with FH, improved lipid management outcomes, and driven awareness and action with healthcare professionals and our populations about the importance of cholesterol in cardiovascular risk.
Led by Health Innovation North East and North Cumbria, the programme involved the implementation of NICE endorsed national guidance for lipid management and prevention of cardiovascular disease.
Across England, innovation is improving cancer services and patient outcomes. Last week the government launched an open call for evidence to inform the National Cancer Plan. Innovation has a critical role to play in supporting the delivery of any National Cancer Plan, and delivering on the government’s three shifts. In order to realise the significant [...]
The Health Innovation Network is delighted to announce the launch of Innovation Insights, a brand-new webinar series designed to highlight the latest in health innovation, offering attendees valuable insights into the adoption and spread of innovation within the health and care landscape. Each interactive webinar will feature: Expert presentations: Delivered by thought leaders across the [...]
Innovation should be at the heart of the NHS 10 Year Plan. Delivering the three shifts and reducing waiting lists simply won’t be possible without innovation. At the Health Innovation Network, we are the innovation adoption experts. We’ll be offering expert advice and support to anyone with an interest in health innovation at this year’s [...]
